Fact CheckerSign in

NCT07341217Recruiting

Chemo Brain Prehab Project

Chemo Brain Prehab Project: Improving Brain Health After Chemotherapy Through Prehabilitation

Source: ClinicalTrials.gov · Last updated 9 Sept 2026

Brief summary (registry, in English)

Colorectal cancer is 37% higher in the North West than the national average and is treated by chemotherapy, including fluorouracil, capecitabine, and oxaliplatin. A side effect of these drugs is loss of memory, forgetfulness, and general brain fog, which can persist for months after the end of treatment. These symptoms are collectively known as 'chemo-brain'. An existing prehabilitation intervention that has been previously developed will be used, which increases fitness and reduces hospital length of stay in colorectal cancer surgery patients, to try to improve the symptoms of chemo-brain in those undergoing chemotherapy and improve quality of life.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
86 (estimated)
First submitted
18 Dec 2025
Start date
7 Jul 2026
Primary completion date
16 Sept 2027
Lead sponsor
Dr. Chris Gaffney
NCT number
NCT07341217

What you commit to

  • Study type: Interventional
  • Planned participants: 86
  • From 7 Jul 2026 to the primary completion date, 16 Sept 2027
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Receiving palliative care.

Other illness

  • Presence of comorbidities that may significantly alter the metabolic response to exercise (e.g., diabetes mellitus).
  • Any contraindication to the multivitamin supplementation (Forceval), including known hypercalcaemia, haemochromatosis, peanut or soya allergy, current use of phenytoin or tetracycline antibiotics, and clinically significant impaired renal or hepatic function.
  • Evidence of pre-existing cognitive impairment, including diagnosis of dementia, other neurodegenerative disorders (e.g., Alzheimer's disease), or clinically indicated mild cognitive impairment.
  • Diagnosis of atrial fibrillation and haematological malignancy.
  • Presence of synchronous cancer.
    • Structured exercise refers to planned and organised physical activity, such as gym workouts, exercise classes or a team sport, which are designed to improve or maintain physical fitness, often with instruction, rules, and goals.

Other

  • Participants without home internet access will be excluded due to the online delivery of the exercise programme.
  • Diagnosis of profound hearing loss.

Who the study is looking for

  • Individuals with stage II or III colorectal cancer undergoing chemotherapy with fluorouracil, capecitabine, or oxaliplatin.
  • Aged 60-85 years old.
  • Fluent in English
  • Male and female participants
  • Not engaged in structured exercise training\* within the six months before providing consent.

Age in the registry: 60 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
East Lancashire Teaching Hospitals NHS Trust
Coordinator of this site? Confirm its status
BlackburnUnited KingdomRecruiting
University Hospitals Morecambe Bay Trust, Royal Lancaster Infirmary
Coordinator of this site? Confirm its status
LancasterUnited KingdomNot yet recruiting
The Clatterbridge Cancer Centre NHS Foundation Trust
Coordinator of this site? Confirm its status
LiverpoolUnited KingdomRecruiting
Lancashire Teaching Hospitals NHS Trust
Coordinator of this site? Confirm its status
PrestonUnited KingdomNot yet recruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.